Get your appointment reminders by text!
Text HEARTPLACE to 622622
or scan the QR CODE with your smart phone.
Dr. Duncan specializes in Nuclear Cardiology and Cardiovascular Disease.
Dr. Ficula specializes in Cardiovascular Disease.
Dr. Mitchell specializes in Nuclear Medicine and Cardiovascular Disease.
Dr. Sanjay Bhargava specializes in interventional cardiology and nuclear cardiology.
Dr. Delaughter specializes in Electrophysiology and Cardiovascular Disease.
HeartPlace is the past, present, and future of cardiology in North Texas. Founded almost 50 years ago, HeartPlace is the oldest and largest cardiovascular group in North Texas. From its small beginning in Dallas, HeartPlace has grown to over 70 physicians throughout the Dallas-Fort Worth metroplex. HeartPlace has been an innovator in cardiovascular services, introducing to the North Texas area procedures such as coronary angiography, angioplasty, coronary stenting, and electrophysiology. This dedication to innovative techniques and procedures has guaranteed our patients the latest and most up-to-date cardiovascular services...
The study in more than 35,000 patients found that the risk of further stroke or heart attack, heart failure or dying due to heart disease at four years was 83% higher in depressed patients with high blood pressure and 36% higher in depressed patients with low blood pressure, compared to those with normal blood pressure and no depressive symptoms. Source: Science Daily Read More Read More
Source: ScienceDaily Endothelial cells residing in the coronary arteries can function as cardiac stem cells to produce new heart muscle tissue, investigators have discovered. The heart has long been considered to be an organ without regenerative potential, said one expert. Recent findings, however, have demonstrated that new heart muscle cells are generated at a low rate, suggesting the presence of cardiac stem cells. The source of these cells was unknown. Read More Read More
Looking at images of their own calcified coronary arteries may be a wake-up call for patients with newly diagnosed coronary artery disease to change their lifestyles, reveals new research. The study was presented today at EuroHeartCare 2015 by Rikke Elmose Mols, a nurse and PhD student in the Department of Cardiology at Aarhus University Hospital-Skejby in Denmark. Source: Medical News Today Read More Read More
Among older men with low testosterone levels, testosterone administration for 3 years compared with placebo did not result in a significant difference in the rates of change in atherosclerosis (thickening and hardening of artery walls), nor was it associated with improved overall sexual function or health-related quality of life, according to a study in JAMA. Source: Medical News Today Read More Read More
People who have peripheral artery disease (PAD) and take cholesterol-lowering drugs called statins have a lower risk of amputation and death than PAD patients who don't take statins. And the higher the dose of statins, the lower the risks, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology, Peripheral Vascular Disease 2016 Scientific Sessions.